MARY ELIZABETH EDGERTON to Female
This is a "connection" page, showing publications MARY ELIZABETH EDGERTON has written about Female.
Connection Strength
0.053
-
A novel, patient-specific mathematical pathology approach for assessment of surgical volume: application to ductal carcinoma in situ of the breast. Anal Cell Pathol (Amst). 2011; 34(5):247-63.
Score: 0.011
-
p53 in Mammary ductal carcinoma in situ, mutations in high-grade lesions only? J Natl Cancer Inst. 2001 May 02; 93(9):666-7.
Score: 0.006
-
MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Cancer Lett. 2019 11 28; 465:12-23.
Score: 0.005
-
Cytologic diagnosis of metastatic ovarian adenocarcinoma in the urinary bladder: a case report and review of the literature. Diagn Cytopathol. 1999 Mar; 20(3):156-9.
Score: 0.005
-
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing. Cell. 2018 01 11; 172(1-2):205-217.e12.
Score: 0.004
-
Genome evolution in ductal carcinoma in situ: invasion of the clones. J Pathol. 2017 Jan; 241(2):208-218.
Score: 0.004
-
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol. 2012 May 21; 301:122-40.
Score: 0.003
-
Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma. Histopathology. 2011 Oct; 59(4):619-30.
Score: 0.003
-
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One. 2011; 6(8):e23543.
Score: 0.003
-
Is it too soon to start reporting HER2 genetic heterogeneity? Arch Pathol Lab Med. 2010 Feb; 134(2):162-3; author reply 163.
Score: 0.003
-
Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res. 2009 May 15; 69(10):4484-92.
Score: 0.002
-
Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol. 2009 Jan 10; 27(2):279-88.
Score: 0.002
-
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol. 2008 Apr; 32(4):544-52.
Score: 0.002